<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="62209">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02078336</url>
  </required_header>
  <id_info>
    <org_study_id>S55859</org_study_id>
    <secondary_id>2013-003991-11</secondary_id>
    <nct_id>NCT02078336</nct_id>
  </id_info>
  <brief_title>Optimization of Procedural Sedation Protocol Used for Dental Care Delivery in People With Mental Disability</brief_title>
  <acronym>OptiSeDent</acronym>
  <official_title>Optimization of Procedural Sedation Protocol Used for Dental Care Delivery in People With Mental Disability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee</authority>
    <authority>Belgium: Federal Agency for Medicines and Health Products, FAMHP</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to compare procedural sedation protocols, specifically applied for the
      delivery of regular dental care in persons with a mental disability.

      The primary objectives are:

        -  To assess the level of cooperation during regular dental care using different
           procedural sedation protocols

        -  To assess patient safety during regular dental care using different sedation protocols

        -  To assess patient comfort and possible side-effects after regular dental care using
           different sedation protocols
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Level of cooperation of patient when receiving regular dental care</measure>
    <time_frame>Participants will be followed for the duration of the dental treatment, an expected average of 30 minutes.</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recording of vital parameters during regular dental care delivery</measure>
    <time_frame>24 hrs</time_frame>
    <safety_issue>No</safety_issue>
    <description>The measure is a composite of
recording of blood pressure
recording of pulse
recording of oxygen saturation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of patient comfort and possible side-effects after dental treatment session</measure>
    <time_frame>24 hrs</time_frame>
    <safety_issue>No</safety_issue>
    <description>The measure of patient comfort and possible side-effects after dental treatment session is a composite of
changes in appetite
changes in toilet behavior
changes in level of consciousness
changes in level of concentration
changes in pattern of epileptic insults
changes in mood
changes in sleeping pattern
changes in level of motor skills</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Dental Care for Disabled</condition>
  <arm_group>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Midazolam Mylan 5 mg/ml solution for injection 15mg Oral use Single dose 45 minutes before dental treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lorazepam / Valium+Akineton+Dehydrobenzperidol+Atropine sulfat</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lorazepam Mylan 2,5 mg tabletten 2.5mg Oral use Single dose 45 minutes before dental treatment
OR
Valium 10 mg/2 ml solution for injection 10mg Intramuscular use Single dose 45 minutes before dental treatment
+ Akineton 5 mg/ml solution for injection 5mg Intramuscular use Single dose 45 minutes before dental treatment
+ Dehydrobenzperidol 5 mg/2 ml solution for injection 0,000125 ml/cm2 Intramuscular use Single dose 45 minutes before dental treatment
+ Atropine sulfate Sterop 0,25mg/1ml solution for injection 0,25mg Intramuscular use Single dose 45 minutes before dental treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam Mylan</intervention_name>
    <arm_group_label>Midazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lorazepam Mylan</intervention_name>
    <arm_group_label>Lorazepam / Valium+Akineton+Dehydrobenzperidol+Atropine sulfat</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Valium + Akineton + Dehydrobenzperidol + Atropine sulfate</intervention_name>
    <arm_group_label>Lorazepam / Valium+Akineton+Dehydrobenzperidol+Atropine sulfat</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Minimum age 18yrs

          -  Patient resides at least 6 months in nursing home &quot;het Gielsbos&quot;.

          -  Patient always gets a sedative protocol to make dental care delivery possible.

          -  Informed consent was obtained from parent/guardian

          -  No medical contra-indication for any of tested sedative protocols

        Exclusion Criteria:

          -  Age under 18yrs

          -  The patient is no resident of the nursing home &quot;het Gielsbos&quot; or lives there for less
             than 6 months.

          -  No need for medicinal support during dental treatment

          -  No informed consent was obtained by parents or the guardian of the patient.

          -  Medical contra-indication for 1 of the sedative protocols
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique Declerck</last_name>
    <role>Principal Investigator</role>
    <affiliation>Katholieke Universiteit Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dominique Declerck</last_name>
    <email>dominique.declerck@med.kuleuven.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ine Opsomer</last_name>
    <email>ine.opsomer@uzleuven.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Katholieke Universiteit Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique Declerck</last_name>
      <email>dominique.declerck@med.kuleuven.be</email>
    </contact>
    <contact_backup>
      <last_name>Ine Opsomer</last_name>
      <email>ine.opsomer@uzleuven.be</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>February 28, 2014</lastchanged_date>
  <firstreceived_date>February 24, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Mental Retardation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atropine</mesh_term>
    <mesh_term>Diazepam</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Droperidol</mesh_term>
    <mesh_term>Biperiden</mesh_term>
    <mesh_term>Lorazepam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
